Tiziana Life Sciences Ltd (TLSA) vs Unicycive Therapeutics, Inc. (UNCY)

Tiziana Life Sciences Ltd and Unicycive Therapeutics, Inc. are both Biotechnology companies. Tiziana Life Sciences Ltd and Unicycive Therapeutics, Inc. are of similar size ($134.0M and $131.1M). Across the 7 metrics below, Tiziana Life Sciences Ltd leads on 4 and Unicycive Therapeutics, Inc. on 3.

Valuation

Metric TLSA UNCY Biotechnology median
P/E n/m n/m 7.88
P/S n/m n/m 11.47
P/B n/m 2.38 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA 0.04 n/m 0.74
EV/Sales n/m n/m 10.73
Earnings yield (51.86%) (37.15%) (28.84%)
Free cash flow yield 0.00% (21.97%) (23.03%)

Profitability

Metric TLSA UNCY Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin — 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% (101.07%) (57.72%)
Return on assets 0.00% (69.05%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric TLSA UNCY Biotechnology median
Revenue growth (TTM) — — 5.64%
EPS growth (last fiscal year) (45.45%) 70.18% —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric TLSA UNCY Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 0.76 3.81 4.73
Net debt to EBITDA 0.19 1.43 0.96

Dividend

Metric TLSA UNCY Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric TLSA UNCY Biotechnology median
Market cap 131.11m 133.98m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack